Chronic binge drinking-induced susceptibility to colonic inflammation is microbiome-dependent.
Fonseca-Pereira D, Bae S, Michaud M, Glickman JN, Garrett WS.
Gut Microbes. 2024 Jan-Dec. 16(1):2392874. PMID: 39163515
Faculty Affiliate in the Department of Molecular Metabolism
Molecular Metabolism
Harvard T.H. Chan School of Public Health
Professor of Medicine
Medicine-Brigham and Women's Hospital
Harvard Medical School
Wendy Garrett is the Irene Heinz Given Professor of Immunology and Infectious Diseases in the Departments of Immunology and Infectious Diseases and of Molecular Metabolism at the Harvard Chan School of Public Health, and also has a Professorship in the Departments of Medicine at Harvard Medical School. Dr. Garrett pursued an MD and PhD at Yale University. She completed a fellowship at the Dana-Farber Cancer Institute and postdoctoral training at Harvard University Medical School.
Dr. Garrett investigates host-microbiota interactions in health and disease. Her research team studies the interplay between the gastrointestinal immune system and the gut microbiota in health, inflammatory bowel disease (IBD) and colorectal cancer (CRC). The Garrett lab focuses on how the gut microbiota influence both innate and adaptive populations and the contribution of these cells to immune homeostasis and disease.
Dr. Garrett's team has identified specific species, pathways, and metabolites made by the microbiota that influence health and disease states. The lab also studies microbes and immune cells that are not only instrumental in potentiating carcinogenesis but are integral to intestinal homeostasis. The multi-faceted research approach includes meta'omics, microbiology, cellular immunology, biochemistry, cell biology, and cancer biology. The lab uses mouse models, human specimens, and primary and transformed mammalian cells and bacterial cells in their experiments in order to move facilely between large human data sets and in vivo and in vitro model systems with a core mission of determining basic biologic mechanism and applying the findings to precision medicine.
The Garrett lab is highly collaborative and works with many laboratories at institutions in the greater Boston area, in Harvard-affiliated hospitals and institutes, and at national and international research centers.
B.S./ M.S., , Combined Bachelor of Science & Master of Science
Yale University
Ph.D.
Yale University
M.D.
Yale University School of Medicine
Medical Oncology Fellowship
Dana-Farber Partners Cancer Care, Laboratory of Laurie H. Glimcher
Fonseca-Pereira D, Bae S, Michaud M, Glickman JN, Garrett WS.
Gut Microbes. 2024 Jan-Dec. 16(1):2392874. PMID: 39163515
Wang K, Lo CH, Mehta RS, Nguyen LH, Wang Y, Ma W, Ugai T, Kawamura H, Ugai S, Takashima Y, Mima K, Arima K, Okadome K, Giannakis M, Sears CL, Meyerhardt JA, Ng K, Segata N, Izard J, Rimm EB, Garrett WS, Huttenhower C, Giovannucci EL, Chan AT, Ogino S, Song M.
Gastroenterology. 2024 Aug 06. PMID: 39117122
Nakatsu G, Andreeva N, MacDonald MH, Garrett WS.
Nat Microbiol. 2024 Jul. 9(7):1644-1654. PMID: 38907007
Ciorba MA, Konnikova L, Hirota SA, Lucchetta EM, Turner JR, Slavin A, Johnson K, Condray CD, Hong S, Cressall BK, Pizarro TT, Hurtado-Lorenzo A, Heller CA, Moss AC, Swantek JL, Garrett WS.
Inflamm Bowel Dis. 2024 May 23. 30(Supplement_2):S5-S18. PMID: 38778627
Kawamura H, Ugai T, Takashima Y, Okadome K, Shimizu T, Mima K, Akimoto N, Haruki K, Arima K, Zhao M, Väyrynen JP, Wu K, Zhang X, Ng K, Nowak JA, Meyerhardt JA, Giovannucci EL, Giannakis M, Chan AT, Huttenhower C, Garrett WS, Song M, Ogino S.
Ann Surg. 2024 May 06. PMID: 38708875
Bhosle A, Bae S, Zhang Y, Chun E, Avila-Pacheco J, Geistlinger L, Pishchany G, Glickman JN, Michaud M, Waldron L, Clish CB, Xavier RJ, Vlamakis H, Franzosa EA, Garrett WS, Huttenhower C.
Mol Syst Biol. 2024 Apr. 20(4):338-361. PMID: 38467837
El Tekle G, Andreeva N, Garrett WS.
Annu Rev Physiol. 2024 Feb 12. 86:453-478. PMID: 38345904
Takashima Y, Kawamura H, Okadome K, Ugai S, Haruki K, Arima K, Mima K, Akimoto N, Nowak JA, Giannakis M, Garrett WS, Sears CL, Song M, Ugai T, Ogino S.
Clin Microbiol Infect. 2024 May. 30(5):630-636. PMID: 38266708
Hull MA, Ow PL, Ruddock S, Brend T, Smith AF, Marshall H, Song M, Chan AT, Garrett WS, Yilmaz O, Drew DA, Collinson F, Cockbain AJ, Jones R, Loadman PM, Hall PS, Moriarty C, Cairns DA, Toogood GJ.
BMJ Open. 2023 11 29. 13(11):e077427. PMID: 38030258
Ugai T, Shimizu T, Kawamura H, Ugai S, Takashima Y, Usui G, Väyrynen JP, Okadome K, Haruki K, Akimoto N, Masugi Y, da Silva A, Mima K, Zhang X, Chan AT, Wang M, Garrett WS, Freeman GJ, Meyerhardt JA, Nowak JA, Song M, Giannakis M, Ogino S.
Clin Transl Immunology. 2023. 12(8):e1453. PMID: 37538192
Wendy Garrett. Irene Heinz Given Professor of Immunology and Infectious Diseases, talks about one thing everyone should know.
At the 6th annual symposium of the Harvard Chan Microbiome in Public Health Center, experts from around the world discussed the many ways that the microbiome contributes to the development and treatment of cancer.
We cannot treat our way out of the rising trend in cancer cases. The only solution is a full-scale defense, so that nobody suffers the disease in the first place.
May 24, 2019 – The microbiome—the collection of trillions of microorganisms throughout the body that plays an important role in numerous diseases—represents a promising frontier in the world of public health. Although it’s a relatively new field of…
In this episode, we speak to a scientist who is examining how our microbiome—the collection of trillions of microbes in and on our bodies—can affect the development of colon cancer.